Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loretta Ferrera

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Pharmacology|January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated MechanismEmanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
Cellular and Molecular Life Sciences : CMLS|March 18, 2025
Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung diseaseLoretta Ferrera, Floriana Cappiello, Arianna Venturini, et al.
Plos One|June 30, 2015
Upregulation of TMEM16A Protein in Bronchial Epithelial Cells by Bacterial PyocyaninEmanuela Caci, Paolo Scudieri, Emma Di Carlo, et al.
Pharmaceutics|November 11, 2022
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious DiseasesFloriana Cappiello, Bruno Casciaro, Maria Rosa Loffredo, et al.
Journal of Medicinal Chemistry|May 12, 2017
Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A)Eric C Truong, Puay W Phuan, Amanda L Reggi, et al.
Science Advances|March 5, 2020
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channelNicoletta Pedemonte, Fabio Bertozzi, Emanuela Caci, et al.
Neurology. Genetics|February 3, 2026
Functional Characterization of a De Novo <i>SCN2A</i> Mixed Variant Linked to Early Infantile Developmental and Epileptic EncephalopathyAnna Corradi, Antonella Riva, Bruno Sterlini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 6, 2016
Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipationOnur Cil, Puay-Wah Phuan, Jung-Ho Son, et al.
Journal of Medicinal Chemistry|September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR PotentiatorsNicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 11, 2025
Polygenic variants in DNA repair genes are associated with neurodevelopmental disorders, regression and increased burdens of somatic variants and short tandem repeat expansionsMaria Cerminara, Giovanni Spirito, Luca Pandolfini, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Pharmacology|January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated MechanismEmanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
Cellular and Molecular Life Sciences : CMLS|March 18, 2025
Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung diseaseLoretta Ferrera, Floriana Cappiello, Arianna Venturini, et al.
Plos One|June 30, 2015
Upregulation of TMEM16A Protein in Bronchial Epithelial Cells by Bacterial PyocyaninEmanuela Caci, Paolo Scudieri, Emma Di Carlo, et al.
Pharmaceutics|November 11, 2022
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious DiseasesFloriana Cappiello, Bruno Casciaro, Maria Rosa Loffredo, et al.
Journal of Medicinal Chemistry|May 12, 2017
Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A)Eric C Truong, Puay W Phuan, Amanda L Reggi, et al.
Science Advances|March 5, 2020
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channelNicoletta Pedemonte, Fabio Bertozzi, Emanuela Caci, et al.
Neurology. Genetics|February 3, 2026
Functional Characterization of a De Novo <i>SCN2A</i> Mixed Variant Linked to Early Infantile Developmental and Epileptic EncephalopathyAnna Corradi, Antonella Riva, Bruno Sterlini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 6, 2016
Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipationOnur Cil, Puay-Wah Phuan, Jung-Ho Son, et al.
Journal of Medicinal Chemistry|September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR PotentiatorsNicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 11, 2025
Polygenic variants in DNA repair genes are associated with neurodevelopmental disorders, regression and increased burdens of somatic variants and short tandem repeat expansionsMaria Cerminara, Giovanni Spirito, Luca Pandolfini, et al.
Pageof 4